2 hedge funds and family offices disclose a GXO position in their latest SEC 13F filing — combined $47.1M in market value.
| # | Investor | Fund | Shares | Value | % of Portfolio | Filed |
|---|---|---|---|---|---|---|
| 1 | Engaged Capital | Engaged Capital LLC | 829,769 | $43.7M | 11.14% | 2025-12-31 |
| 2 | Ray Dalio | Bridgewater Associates LP | 65,149 | $3.4M | 0.02% | 2026-03-31 |
As of the latest 13F window, 2 tracked superinvestors hold GXO. The largest disclosed position is Engaged Capital at $43.7M (11.1% of portfolio).
13F filings are due 45 days after each quarter end and capture long-equity positions held by U.S. institutional managers with $100M+ AUM. Use this page to see exactly who is buying GXO, how concentrated each position is, and the implied conviction level relative to the rest of each investor's book.
Key takeaways
2 hedge funds and family offices disclose a GXO position in their latest SEC 13F filing — combined $47.1M in market value.
| # | Investor | Fund | Shares | Value | % of Portfolio | Filed |
|---|---|---|---|---|---|---|
| 1 | Engaged Capital | Engaged Capital LLC | 829,769 | $43.7M | 11.14% | 2025-12-31 |
| 2 | Ray Dalio | Bridgewater Associates LP | 65,149 | $3.4M | 0.02% | 2026-03-31 |
As of the latest 13F window, 2 tracked superinvestors hold GXO. The largest disclosed position is Engaged Capital at $43.7M (11.1% of portfolio).
13F filings are due 45 days after each quarter end and capture long-equity positions held by U.S. institutional managers with $100M+ AUM. Use this page to see exactly who is buying GXO, how concentrated each position is, and the implied conviction level relative to the rest of each investor's book.
Key takeaways
